Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOLVE-AMI
2024-514416-28-00Phase 4Authorised
- Sponsor
- Karolinska Institutet
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial in Left ventricular thrombosis (LVT) and myocardial infarction (MI) comparing Apixaban arm with Warfarin arm (2 arms). Primary endpoint: Thrombus resolution at 3 months. Planned start Apr 2025; status: authorised.
02
Drugs
apixabanwarfarin
03
Conditions
Left ventricular thrombosis (LVT)myocardial infarction (MI)
Beyond the preview
Go deeper on 2024-514416-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514416-28-00.